Oncology
-
healthEli Lilly Announces Landmark $2.75 Billion AI Alliance With Insilico Medicine
Eli Lilly forms a strategic partnership with Insilico Medicine valued at up to $2.75 billion. The deal leverages generative AI to significantly accelerate pharmaceutical drug discovery timelines.
-
healthFitness and Body Composition Boost Breast Cancer Chemo Tolerance
Higher fitness and lean body mass improve chemotherapy delivery in breast cancer patients.
-
healthTakeda Restructures to Accelerate Late-Stage Drug Pipeline
Takeda launches a major restructuring to cut $1.25B in costs by 2028 and redirect savings into R&D for oncology, neuroscience, and rare diseases.
-
healthPsychological Support Eases Parental Anxiety in Pediatric Palliative Care
Meta-analysis confirms short-term mental health benefits for parents via psychological interventions, highlighting critical data gaps in non-oncology settings.
-
techRoche Deploys 3,500 NVIDIA GPUs to Accelerate Global Drug Discovery
Pharmaceutical giant Roche integrates NVIDIA Blackwell architecture into R&D infrastructure to reduce development timelines and enhance diagnostic accuracy worldwide.
-
healthServier Taps kyron.bio for Next-Gen Antibody Therapeutics
Servier partners with kyron.bio to advance antibody therapeutics for oncology and autoimmune diseases, focusing on precision glycoengineering for enhanced drug performance and patient outcomes.
-
healthCancer Diagnosis Post-Cardiac Surgery Linked to Significantly Shorter Survival
New research reveals that patients diagnosed with cancer before or after cardiac surgery face substantially reduced long-term survival rates compared to those without a cancer history.
-
healthCervical Cancer Crisis: Canada Faces 'Fastest-Rising' Rates Amidst Policy Failures
Canadian doctors warn of a growing cervical cancer crisis, urging immediate policy changes to address stalled vaccination rates and inequitable screening access.